Selecting units from a population for measurement; where representativeness is won or lost.
For practitioners working with generative tools, sampling is the act of drawing each output token or pixel from the model's probability distribution, steered by decoding parameters: temperature, top-p, top-k, and seeds. It is the dial that trades novelty against fidelity — low-temperature sampling yields safe, on-brief output; higher settings buy surprise at the cost of coherence and factual drift. Craft knowledge here means knowing which sampling settings, with which seeds, make a result reproducible enough to deliver to a client.
In practice: Choose and record decoding parameters and seeds deliberately, matching sampling randomness to the brief, and state which sense of 'sampling' a contract or clearance actually covers.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
For credit- and market-model developers, sampling is the disciplined partition and selection of data for development and testing: stratified draws that preserve default rates across segments, out-of-sample holdouts, and out-of-time windows that separate fitting from evaluation. Sample-period choice is a model-risk decision in its own right — a development sample drawn from a benign part of the credit cycle understates tail behavior — so validators scrutinize sampling windows and re-weighting choices as closely as the model form.
In practice: Justify the development sample's window, segmentation, and holdout design; test performance out-of-sample and out-of-time; and flag samples drawn from unrepresentative parts of the cycle.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In audit and compliance testing across financial firms, sampling is the statistically grounded selection of transactions, files, or controls for examination when full-population testing is impractical: attribute samples sized to a confidence level and tolerable error rate, risk-based oversamples of high-value items, and documented random selection so findings extrapolate defensibly. A sample here is evidence in a control opinion — its design must survive challenge by regulators and external auditors, so method and seed are recorded in the workpapers.
In practice: Size and draw a defensible transaction sample for a stated confidence level and tolerable error rate, document the method, and extrapolate exceptions to a population-level conclusion.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In medical-AI development, sampling is the construction of study and training cohorts from clinical data streams: eligibility criteria applied to EHR extracts, site and period selection, and case-control ratios. Because cohorts are typically convenience samples from the institutions that host the data, representativeness is established empirically rather than by design — through external validation at other sites and disaggregated subgroup performance — and a cohort is judged adequate when performance transfers to the intended care setting and patient mix.
In practice: Specify cohort eligibility and site selection, document who is absent from the sample, and demand external validation before extending claims beyond the sampled care settings.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
In official statistics, sampling is a designed procedure: units drawn from a maintained frame with known, non-zero inclusion probabilities, so that estimates carry design-based weights, published sampling errors, and defensible population inference. Nonresponse follow-up, frame coverage checks, and calibration to auxiliary totals are part of the operation, and documented sampling error is a quality indicator required of statistical offices. Administrative or web-scraped sources may supplement a design, but inference from them demands explicit quality frameworks, not scale alone.
In practice: Design and document a probability sample from an adequate frame, publish sampling errors and response rates, and justify any use of non-probability sources against a quality framework.
OmniGloss seed synthesis, 2026 (machine-drafted, pending expert validation)
Communities disagree over what licenses inference from a sample to a population. Official statistics holds that only designed probability sampling with known inclusion probabilities yields defensible population estimates, and that massive found datasets remain biased regardless of size. Machine-learning practice, exemplified in healthcare AI, treats large convenience cohorts — corrected, externally validated, and checked for subgroup performance after the fact — as adequate warrant for deployment claims.